<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04663698</url>
  </required_header>
  <id_info>
    <org_study_id>PLB2019</org_study_id>
    <nct_id>NCT04663698</nct_id>
  </id_info>
  <brief_title>The Effect of Volitional Pursed-lips Breathing</brief_title>
  <acronym>PLB</acronym>
  <official_title>Evaluation of PLB Physiology in COPD - Untersuchung Zur Physiologie Der Lippenbremse Bei COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karl Josef Franke, PD DR med</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut für Pneumologie Hagen Ambrock eV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Simulation of pursed-lips breathing by defined stenoses in pulmonary function diagnostics to&#xD;
      quantify the effect of the pursed-lips breathing&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since many years it is recommended for COPD patients to reduce the crossdiameter of the lips&#xD;
      in order to improve the exhalation by means of so-called pursed-lips breathing (PLB). But the&#xD;
      effects have never been studied quantitatively. In this study, the PLB effect is simulated&#xD;
      during lung function diagnostics, using different sized resistors inserted into the routine&#xD;
      mouthpiece of the flow sensor to resemble the effective airway resistances of a PLB maneuver.&#xD;
      This prospective, randomized study includes 20 healthy subjects and 50 COPD patients, who&#xD;
      will perform lung function testing with 4 different sized resistors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 11, 2019</start_date>
  <completion_date type="Actual">March 30, 2021</completion_date>
  <primary_completion_date type="Actual">January 8, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lung function parameter FEV1</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>Measuring of lung function parameters with different resistors to simulate PLB unit: L, measured with der MasterScreen™ Body, CareFusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PEF - expiratory Peak Flow</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>unit: L, measured with der MasterScreen™ Body, CareFusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RV%TLC</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>unit: %, measured with der MasterScreen™ Body, CareFusion</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lung-healthy subjects, randomized lung function testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients, randomized lung function testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients, randomized lung function testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients, randomized lung function testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients, randomized lung function testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baseline</intervention_name>
    <description>Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Patient 1</arm_group_label>
    <arm_group_label>Patient 2</arm_group_label>
    <arm_group_label>Patient 3</arm_group_label>
    <arm_group_label>Patient 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MESH-Resistor 5</intervention_name>
    <description>Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (5hPa/L) to create laminar airflow</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Patient 1</arm_group_label>
    <arm_group_label>Patient 3</arm_group_label>
    <arm_group_label>Patient 4</arm_group_label>
    <other_name>Rudolph Flow Resistance Standards; HANS RUDOLPH, Inc.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MESH-Resistor 10</intervention_name>
    <description>Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (10hPa/L) to create laminar airflow</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Patient 1</arm_group_label>
    <other_name>Rudolph Flow Resistance Standards; HANS RUDOLPH, inc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Perforated Resistor 7</intervention_name>
    <description>Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 7mm) to create a turbulent airflow</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Patient 2</arm_group_label>
    <arm_group_label>Patient 3</arm_group_label>
    <other_name>900MR405; Fisher&amp;Paykel Healthcare</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Perforated Resistor 11</intervention_name>
    <description>Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 11mm) to create a turbulent airflow</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Patient 2</arm_group_label>
    <arm_group_label>Patient 4</arm_group_label>
    <other_name>900MR406; Fisher&amp;Paykel Healthcare</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  COPD (GOLD I- IV)&#xD;
&#xD;
          -  Stable respiratory situation that allows routine lung funtion&#xD;
&#xD;
          -  capable of communication&#xD;
&#xD;
        Healthy:&#xD;
&#xD;
          -  Lung Healthy&#xD;
&#xD;
          -  capable of communication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Invasive Ventilation&#xD;
&#xD;
          -  Other serious acute physical illnesses that require immediate intensive medical&#xD;
             treatment&#xD;
&#xD;
          -  Acute hypercapnic decompensation with a pH &lt; 7.35 in the capillary BGA&#xD;
&#xD;
          -  Pregnancy or Nursing&#xD;
&#xD;
          -  Not able to give consent&#xD;
&#xD;
          -  Not willing or able to follow the study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Märkische Kliniken GmbH, Klinikum Lüdenscheid</name>
      <address>
        <city>Lüdenscheid</city>
        <state>NRW</state>
        <zip>58515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institut für Pneumologie Hagen Ambrock eV</investigator_affiliation>
    <investigator_full_name>Karl Josef Franke, PD DR med</investigator_full_name>
    <investigator_title>Clinical Director</investigator_title>
  </responsible_party>
  <keyword>Pursed-lips Breathing</keyword>
  <keyword>Resistor</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

